Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment
T. Dantoine, S. Auriacombe, M. Sarazin, H. Becker, J-J Pere, I. BourdeixVolume:
60
Year:
2006
Language:
english
Pages:
9
DOI:
10.1111/j.1368-5031.2005.00769.x
File:
PDF, 289 KB
english, 2006